Evidence map›Paper›PMID 35646766›Full record

ArticleFrontiers in public health2022

Case Report: Severe

Xiaomin Zhang, Peng Feng, Pengfei Meng, Dongfang Li, Huizhong Gao, Yang Zhao, Jingjing Yuan, Yongqing Wang, Han Xia

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Occurrence of Antimicrobial-ResistantVeterinary medicine international · 2026
    Article
  3. Analysis of Clinical and Microbiological Features ofInfection and drug resistance · 2023
    Article
  4. Clinical Characteristics and Treatment ofInfection and drug resistance · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xiaomin ZhangDepartment of Neurology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Peng FengDepartment of Neurology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Pengfei MengDepartment of Neurology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Dongfang LiDepartment of Neurology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Huizhong GaoDepartment of Neurology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Yang ZhaoDepartment of Neurology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Jingjing YuanAcupuncture Hospital of Shanxi Province, Taiyuan, China.
Yongqing WangDepartment of Neurology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Han XiaHugobiotech Co., Ltd., Department of Scientific Affairs, Beijing, China.
Second Hospital of Shanxi Medical University · CNShanxi Medical University · CNShanxi Province Hospital of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Case Presentation: A 39-year-old male patient was admitted to our hospital due to fever for more than 10 days and disturbance of consciousness accompanied by convulsions for 2 days. Metagenomic next-generation sequencing (mNGS) results showed Conclusions: It is necessary to carry out infection and immunity screening in patients with severe encephalitis, especially for immunocompromised patients. mNGS plays a pivotal role in screening patients with severe and difficult neurological diseases.

Indexed as

Demyelinating DiseasesEncephalitisHashimoto DiseaseListeriaAdultHumansMaleCNS demyelinating diseasescomplicated or secondary autoimmune encephalitismetagenomic next-generation sequencingpathogen detectionsevere Listeria encephalitis

Identifiers

PMID35646766
PMCPMC9133549
OpenAlexW4280641153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.